<DOC>
	<DOC>NCT01484119</DOC>
	<brief_summary>This study will assess the efficacy and safety of ACT-129968 in adolescent, adult and elderly patients with seasonal allergic rhinitis, due to mountain cedar pollen.</brief_summary>
	<brief_title>Efficacy, Safety, and Tolerability Study of ACT-129968 in Patients With Seasonal Allergic Rhinitis</brief_title>
	<detailed_description />
	<mesh_term>Rhinitis, Allergic</mesh_term>
	<mesh_term>Rhinitis</mesh_term>
	<mesh_term>Rhinitis, Allergic, Seasonal</mesh_term>
	<mesh_term>Cetirizine</mesh_term>
	<criteria>Inclusion Criteria Males and females aged 1276 years with documented clinical history of symptomatic seasonal allergic rhinitis associated with mountain cedar pollen for the last 2 years. Evening reflective Total Nasal Symptom Score (p.m.rTNSS) at least 42 out of a maximum potential score of 84 over the 7day runin period, or &gt; or = 6 out of a maximum score of 12 on each of the last 4 consecutive days during the runin period. Exclusion Criteria Nonallergic rhinitis. Severe physical nasal obstruction. Acute or significant chronic sinusitis. Bacterial or viral infection of the upper or lower respiratory tract, nasal sinuses, or middle ear. Ongoing chronic respiratory disorders. Asthma requiring use of shortacting beta2agonists &gt; 2 times a week or any asthma treatment other than inhaled shortacting beta2agonists. Diagnosis of aspirin or nonsteroidal antiinflammatory drug (NSAID)induced asthma. Nasal biopsy or surgery, sinus surgery, or perforation within the 8 weeks prior to the Screening Visit. Ocular surgery within the 8 weeks prior to the Screening Visit. Ocular infections (bacterial or viral) within the 4 weeks before screening. Use of forbidden medications (prescribed or overthecounter [OTC]) Congenital or acquired severe immunodeficiency or known Human immunodeficiency virus (HIV)infection.</criteria>
	<gender>All</gender>
	<minimum_age>12 Years</minimum_age>
	<maximum_age>76 Years</maximum_age>
	<verification_date>March 2013</verification_date>
	<keyword>seasonal allergic rhinitis</keyword>
</DOC>